journal article·2016-07-03

The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer

Leila Kafshdooz, Taiebeh Kafshdooz, Zohreh Razban, Abolfazl Akbarzadeh

Publisher page

Abstract

The development of specialized nanoparticles (NPs) for use in the detection and treatment of cancer is increasing. In the last few years, gold nanoparticles (AuNPs) have been greatly studied in biological and photothermal therapeutic status. AuNPs can bind to a wide range of organic molecules, and their synthesis is easy. In this review, we summarize the characteristics of AuNPs, their contributions to tumor destruction, their toxicity, and their potential in the treatment of breast and ovarian cancer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Nanotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran

Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

References (68)

Show source-provided references
1. 10.1038/nrc112310.1038/nrc1123 ↗
2. 10.1021/nl101140t10.1021/nl101140t ↗
3. 10.1586/erm.12.5010.1586/erm.12.50 ↗
4. 10.1021/ja076333e10.1021/ja076333e ↗
5. 10.1038/nmat89110.1038/nmat891 ↗
6. 10.1038/3502522010.1038/35025220 ↗
7. 10.1021/mp100207t10.1021/mp100207t ↗
8. 10.1186/1757-2215-2-2110.1186/1757-2215-2-21 ↗
9. 10.1021/nn900743v10.1021/nn900743v ↗
10. 10.2147/NSA.S370710.2147/NSA.S3707 ↗
11. 10.1002/cncr.1134510.1002/cncr.11345 ↗
12. 10.1016/j.biomaterials.2011.11.06910.1016/j.biomaterials.2011.11.069 ↗
13. 10.1021/nl052396o10.1021/nl052396o ↗
14. 10.1021/bc050335b10.1021/bc050335b ↗
15. 10.1021/bc300158k10.1021/bc300158k ↗
16. 10.1021/bc900221210.1021/bc9002212 ↗
17. 10.32607/20758251-2011-3-2-34-5510.32607/20758251-2011-3-2-34-55 ↗
18. 10.1021/nl802915q10.1021/nl802915q ↗
19. 10.3322/canjclin.50.1.710.3322/canjclin.50.1.7 ↗
20. 10.1211/jpp.60.8.000510.1211/jpp.60.8.0005 ↗
21. 10.1088/0031-9155/49/18/N0310.1088/0031-9155/49/18/N03 ↗
22. 10.1111/j.1747-0285.2005.00324.x10.1111/j.1747-0285.2005.00324.x ↗
23. 10.1038/ncponc063710.1038/ncponc0637 ↗
24. 10.1073/pnas.163515810010.1073/pnas.1635158100 ↗
25. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
26. 10.1007/s10103-007-0470-x10.1007/s10103-007-0470-x ↗
27. 10.1021/jp057170o10.1021/jp057170o ↗
28. 10.1007/978-0-387-74911-2_3110.1007/978-0-387-74911-2_31 ↗
29. 10.1016/j.colsurfb.2012.02.03910.1016/j.colsurfb.2012.02.039 ↗
30. 10.1039/C0CS00018C10.1039/C0CS00018C ↗
31. 10.1155/2011/20218710.1155/2011/202187 ↗
32. 10.1023/A:101642010254910.1023/A:1016420102549 ↗
33. 10.1126/science.247998610.1126/science.2479986 ↗
34. 10.1016/j.canlet.2008.09.02410.1016/j.canlet.2008.09.024 ↗
35. 10.1021/jp984796o10.1021/jp984796o ↗
36. 10.1021/jp990387w10.1021/jp990387w ↗
37. 10.1021/cr030078910.1021/cr0300789 ↗
38. 10.1021/nn901742q10.1021/nn901742q ↗
39. 10.1142/S0192415X8500014910.1142/S0192415X85000149 ↗
40. Maunsbach AB · Biomedical Electron Microscopy: Illustrated Methods and Interpretations. San Diego, London: Academic Press · 1998
41. McGuire WP · Semin Oncol · 1998 · 25 · 340
42. 10.1021/ja015556g10.1021/ja015556g ↗
43. 10.1158/1078-0432.CCR-04-248210.1158/1078-0432.CCR-04-2482 ↗
44. 10.1186/bcr161210.1186/bcr1612 ↗
45. Ojeda F · Scanning Microsc. (3) · 1994 · 645
46. 10.1080/1071754049043389510.1080/10717540490433895 ↗
47. 10.1364/OE.16.00159010.1364/OE.16.001590 ↗
48. 10.1039/B913224D10.1039/B913224D ↗
49. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
50. 10.18632/oncotarget.22710.18632/oncotarget.227 ↗
51. 10.1111/1523-1747.ep1260621510.1111/1523-1747.ep12606215 ↗
52. 10.1128/MCB.00484-1010.1128/MCB.00484-10 ↗
53. 10.1080/0020745021201810.1080/00207450212018 ↗
54. 10.1038/386671a010.1038/386671a0 ↗
55. 10.1021/ar010094x10.1021/ar010094x ↗
56. Senger DR · Cancer Res · 1986 · 46 · 5629
57. Sokolov K · Cancer Res · 2003 · 63 · 1999
58. 10.1021/ja067206610.1021/ja0672066 ↗
59. 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F ↗
60. 10.1208/aapsj090201510.1208/aapsj0902015 ↗
61. 10.1182/blood-2005-03-126310.1182/blood-2005-03-1263 ↗
62. 10.1517/14712598.8.8.106310.1517/14712598.8.8.1063 ↗
63. 10.1021/nn203217710.1021/nn2032177 ↗
64. 10.18632/oncotarget.220310.18632/oncotarget.2203 ↗
65. 10.1021/ja900790v10.1021/ja900790v ↗
66. 10.1186/1757-2215-3-1910.1186/1757-2215-3-19 ↗
67. 10.1073/pnas.103295410010.1073/pnas.1032954100 ↗
68. 10.3402/nano.v3i0.1849610.3402/nano.v3i0.18496 ↗